Zobrazeno 1 - 10
of 15
pro vyhledávání: '"H F, Dullens"'
Autor:
H, Struikmans, D H, Rutgers, G H, Jansen, H F, Dullens, L, Oosten, C A, Tulleken, I, van der Tweel, J J, Battermann
Publikováno v:
Radiation oncology investigations. 7(4)
Prognostic relevance of cell proliferation markers was evaluated in 27 glioma patients. By 1) flow cytometry (FCM), i.e., S-phase fraction (SPF), and BrdUrd-labeling index (LIfcm); 2) immunohistochemistry (IHC), i.e., BrdUrd-labeling index (LIihc) an
Autor:
L A, Everse, I B, Renes, I M, Jürgenliemk-Schulz, D H, Rutgers, M R, Bernsen, H F, Dullens, W, Den Otter, J J, Battermann
Publikováno v:
International journal of cancer. 72(6)
Tumor recurrence and outgrowth of metastases limit the therapeutical effect of radiotherapy. We have tested whether these problems can be overcome by supplementing radiotherapy with locoregional interleukin-2 (IL-2) treatment. The SL2 lymphoma and th
Publikováno v:
Anticancer research. 16(1)
Natural killer cells display spontaneous, non-MHC-restricted cytotoxicity against tumour cells, which is strongly enhanced after incubation with IL-2. The molecular background of the increased anti-tumour activity of these lymphokine-activated killer
Publikováno v:
Pharmaceutical research. 10(12)
Interleukin-2 (IL-2) incorporation in liposomes was studied under different conditions. Information was obtained on the mechanism of interaction of glycosylated recombinant IL-2 with liposomal bilayers. This information was utilized to formulate lipo
Publikováno v:
Invasionmetastasis. 13(5)
The omental lymphoid organ (OLO) is a part of the greater omentum composed of vascularized spots containing lymphocytes, plasma cells and macrophages located in a regular pattern between fat cells. To gain insight in the involvement of the OLO in the
Publikováno v:
In vivo (Athens, Greece). 5(6)
The histology of Interleukin-2 induced tumour regression is presented. DBA/2 mice were injected simultaneously ip (intraperitoneally) and sc (subcutaneously) with 2 x 10(4) and 2 x 10(5) syngeneic SL2 lymphosarcoma cells, respectively. After treatmen
Publikováno v:
In vivo (Athens, Greece). 5(6)
We have demonstrated that local treatment with low doses of IL-2 can cure mice bearing a large burden of metastasized SL2 lymphoma. Different mechanisms lead to rejection of ascitic SL2 tumor and solid s.c. SL2 tumor. For local rejection of ascitic t
Publikováno v:
Invasionmetastasis. 11(4)
The omental lymphoid organ (OLO) is a part of the greater omentum composed of vascularized milky spots situated between fat cells and containing lymphocytes, plasma cells and macrophages. We analysed the disappearance of intraperitoneally injected tu
Autor:
H F, Dullens, W, Den Otter
Publikováno v:
Cancer research. 34(7)
Autor:
H F, Dullens, J, Hilgers, B J, Spit, E, De Heer, R A, De Weger, C D, Van Basten, W, Den Otter
Publikováno v:
International journal of tissue reactions. 4(1)
Cell surface markers, enzymatic patterns, proliferation characteristics and metastatic behaviour of the DSA/2 derived SL2 lymphoma were determined. SL2 cells are sensitive to a heterologous antiserum to murine T-cells and to allo-antisera for Thy 1.2